Technical Analysis for CHRS - Coherus BioSciences, Inc.

Grade Last Price % Change Price Change
grade D 9.98 -0.40% -0.04
CHRS closed down 0.4 percent on Thursday, December 13, 2018, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CHRS trend table...

Date Alert Name Type % Chg
Dec 13 Stochastic Buy Signal Bullish 0.00%
Dec 13 Multiple of Ten Bearish Other 0.00%
Dec 13 Oversold Stochastic Weakness 0.00%
Dec 12 Multiple of Ten Bullish Other -0.40%
Dec 12 Oversold Stochastic Weakness -0.40%
Dec 11 Multiple of Ten Bearish Other 1.01%
Dec 11 Down 3 Days in a Row Weakness 1.01%
Dec 11 Lower Bollinger Band Touch Weakness 1.01%
Dec 11 Oversold Stochastic Weakness 1.01%
Dec 10 Stochastic Buy Signal Bullish 0.30%

Older signals for CHRS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420, an adalimumab biosimilar candidate that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701, a pegfilgrastim biosimilar candidate, which has completed a Phase I study for the treatment of breast cancer patients exhibiting chemotherapy-induced neutropenia. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus Biosciences, Inc. in April 2012. Coherus Biosciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Is CHRS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.66
52 Week Low 8.4
Average Volume 792,563
200-Day Moving Average 14.4764
50-Day Moving Average 11.9072
20-Day Moving Average 10.9925
10-Day Moving Average 10.39
Average True Range 0.7789
ADX 22.93
+DI 12.8734
-DI 22.3962
Chandelier Exit (Long, 3 ATRs ) 10.1733
Chandelier Exit (Short, 3 ATRs ) 11.8467
Upper Bollinger Band 12.4929
Lower Bollinger Band 9.4921
Percent B (%b) 0.16
BandWidth 27.298613
MACD Line -0.6033
MACD Signal Line -0.5613
MACD Histogram -0.042
Fundamentals Value
Market Cap 512.43 Million
Num Shares 51.3 Million
EPS -2.60
Price-to-Earnings (P/E) Ratio -3.84
Price-to-Sales 3.37
Price-to-Book 17.33
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.73
Resistance 3 (R3) 10.77 10.55 10.61
Resistance 2 (R2) 10.55 10.36 10.54 10.56
Resistance 1 (R1) 10.27 10.24 10.16 10.23 10.52
Pivot Point 10.05 10.05 10.00 10.04 10.05
Support 1 (S1) 9.77 9.86 9.66 9.73 9.44
Support 2 (S2) 9.55 9.74 9.54 9.40
Support 3 (S3) 9.27 9.55 9.36
Support 4 (S4) 9.23